Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$304.11 - $351.99 $39,534 - $45,758
-130 Reduced 9.83%
1,193 $412,000
Q4 2023

Feb 09, 2024

BUY
$269.37 - $365.04 $164,315 - $222,674
610 Added 85.55%
1,323 $427,000
Q3 2023

Nov 01, 2023

BUY
$350.25 - $422.63 $249,728 - $301,335
713 New
713 $255,000
Q1 2023

Apr 28, 2023

BUY
$418.69 - $503.0 $11,723 - $14,084
28 Added 5.03%
585 $280,000
Q4 2022

Feb 10, 2023

SELL
$351.71 - $456.01 $11,254 - $14,592
-32 Reduced 5.43%
557 $234,000
Q3 2022

Nov 14, 2022

SELL
$412.59 - $563.26 $160,084 - $218,544
-388 Reduced 39.71%
589 $246,000
Q2 2022

Jul 20, 2022

SELL
$463.67 - $597.16 $196,596 - $253,195
-424 Reduced 30.26%
977 $484,000
Q1 2022

May 16, 2022

BUY
$524.57 - $735.42 $56,653 - $79,425
108 Added 8.35%
1,401 $789,000
Q4 2021

Jan 21, 2022

SELL
$708.84 - $794.68 $10,632 - $11,920
-15 Reduced 1.15%
1,293 $977,000
Q3 2021

Nov 15, 2021

BUY
$657.71 - $825.77 $15,127 - $18,992
23 Added 1.79%
1,308 $975,000
Q2 2021

Aug 16, 2021

SELL
$576.64 - $649.04 $28,255 - $31,802
-49 Reduced 3.67%
1,285 $828,000
Q1 2021

May 14, 2021

SELL
$547.01 - $662.35 $81,504 - $98,690
-149 Reduced 10.05%
1,334 $762,000
Q4 2020

Feb 16, 2021

BUY
$510.68 - $643.45 $168,524 - $212,338
330 Added 28.62%
1,483 $865,000
Q3 2020

Nov 16, 2020

BUY
$454.43 - $535.6 $293,561 - $345,997
646 Added 127.42%
1,153 $594,000
Q2 2020

Aug 14, 2020

BUY
$334.87 - $493.06 $169,779 - $249,981
507 New
507 $229,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.1B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Wealthfront Advisers LLC Portfolio

Follow Wealthfront Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthfront Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthfront Advisers LLC with notifications on news.